Api creatine kinase assay set
Taiwan·Risk Class 2·FISHER DIAGNOSTICS, A DIVISION OF FISHER SCIENTIFIC COMPANY, LLC, A PART OF THERMO FISHER SCIENTIFIC INC.;; ABBOTT GMBH·Registered Dec 14, 2018 – Dec 14, 2028Active- Analysis ID
- a9cb1275f5044b29215d05233fea8c2d
- Customs Code
- DHA05603197300
- Manufacturer Country
- United States;;Germany
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
- Intended Use
- This product is paired with the Alinity c Analyzer to quantify creatine kinase in human serum or plasma.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1215 Creatine phosphokinase/creatine kinase or isoenzyme testing system
- Import Information
- Contract manufacturing;; input
- Registration Date
- Dec 14, 2018
- Expiry Date
- Dec 14, 2028
Access comprehensive regulatory information for Api creatine kinase assay set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a9cb1275f5044b29215d05233fea8c2d and manufactured by FISHER DIAGNOSTICS, A DIVISION OF FISHER SCIENTIFIC COMPANY, LLC, A PART OF THERMO FISHER SCIENTIFIC INC.;; ABBOTT GMBH. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.